Home Corporate Products Pipeline Technologies Investors Publications News and Events
 Search 

Rosetta Genomics is a leading molecular diagnostics company advancing minimally-invasive molecular tests based on its proprietary microRNAs, and platform technologies. Following the launch of three cancer tests in the beginning of 2009, the Company is now working to develop additional cancer tests which are expected to be commercialized within the next two years.

January 13, 2009
  Rosetta Genomics announces issuance of three U.S. patents...More
 
January 13, 2009
  Rosetta Genomics fortifies patent position with human allowance of claims covering human microRNAs miR-21 and hcmv-miR-UL112...More

 
April 17-21  - AACR 101st Annual Meeting. Washington D.C.More 
   

 
 March 22-24  - MicroRNA in Human Disease and Development. Camebridge, MA. More 
   
Terms Of Use | Privacy | Sitemap | Contact Us | Home
© 2008 All rights reserved to Rosetta Genomics
Rosetta Genomics